Practice Areas:
M&A
Jurisdictions:
Industry Sectors:
Pharmaceuticals and life sciences
Technology and telecommunications
Client feedback
"Matthias Staehelin has an impressive transactional and intellectual property practice that he leverages to support clients in a variety of financing, dealmaking and life sciences issues."
Biography
Matthias Staehelin is primarily involved in the life sciences and IT industries; he regularly advises on the sale and purchase of companies (M&A), financing through investors (private equity and venture capital), licensing and collaboration agreements (including joint ventures), introductions to the stock exchange (IPOs) and restructuring.
Recent transactional highlights
- NBE Therapeutics sold to Boehringer Ingelheim for EUR 1.1bn
- Sale of Symetis to Boston Scientific for USD 435m
- Polyphor grants Fosun Pharma license for China
- Collaboration of AC Immune with Lilly
- Numerous financing transactions (Noema Pharma 54m, Polyneuron Pharmaceuticals 36.5m, NBE Therapeutics 40 m,
Practice areas
- Capital markets: Equity
- M&A
- Private equity
- Private equity funds
- Restructuring and insolvency
Sector specialisations
- Healthcare
- Industrials
- Pharma and life sciences
- Real estate
Association memberships
- BioValley Basel Association (President)
- BioValley Business Angels Club (BioBAC) (Board Member)
Academic qualifications
- University of Basel (Dr. iur., 1993)
- College: Internationalisierung des Privatrechts Freiburg i.B. (1992/93)
- College of Europe, Bruges (Master of Advanced European Studies, 1992/Diplome des Hautes Etudes Europeennes, 1991)
- University of Basel (lic. iur., 1990)
Address:
Tel:+41 58 211 33 53
Email:Contact this practitioner
Website:https://www.vischer.com/en/team/matthias-staehelin/
Zurich